Michio Imamura Selected Research

Michio Imamura Research Topics

Disease

79	Infections 10/2022 - 03/2005
64	Hepatocellular Carcinoma (Hepatoma) 06/2022 - 09/2002
49	Chronic Hepatitis C 01/2021 - 07/2006
26	Neoplasms (Cancer) 10/2021 - 05/2007
22	Fibrosis (Cirrhosis) 07/2022 - 12/2004
22	Liver Cirrhosis (Hepatic Cirrhosis) 01/2021 - 06/2004
18	Chronic Hepatitis B 10/2022 - 02/2006
14	Neoplasm Metastasis (Metastasis) 10/2021 - 11/2011
14	Hepatitis C 09/2020 - 05/2009
11	Liver Diseases (Liver Disease) 10/2022 - 09/2010
11	Hepatitis B 01/2021 - 11/2006
9	Hepatitis 01/2021 - 07/2006
8	Thrombosis (Thrombus) 10/2021 - 11/2011
6	Hepatic Encephalopathy 11/2020 - 07/2013
6	Non-alcoholic Fatty Liver Disease 08/2020 - 03/2014
6	Disease Progression 04/2020 - 12/2007
6	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 01/2018 - 07/2010
4	Insulin Resistance 03/2022 - 12/2014
4	Chronic Hepatitis (Chronic Active Hepatitis) 12/2020 - 03/2017
4	Type 2 Diabetes Mellitus (MODY) 01/2018 - 03/2014
3	Liver Neoplasms (Liver Cancer) 10/2022 - 05/2009
3	Viremia 12/2021 - 11/2005
3	Inflammation (Inflammations) 07/2019 - 01/2005
3	Acute Liver Failure (Fulminant Hepatic Failure) 12/2017 - 08/2014
3	Anemia 06/2017 - 06/2011
3	Esophageal and Gastric Varices (Esophageal Varices) 07/2013 - 03/2009
2	Fatty Liver 07/2022 - 05/2016
2	Hypoglycemia (Reactive Hypoglycemia) 03/2022 - 02/2017
2	Glucose Intolerance 03/2022 - 02/2017
2	Liver Failure 02/2021 - 06/2008
2	Necrosis 01/2021 - 01/2018
2	Carcinogenesis 11/2020 - 07/2006
2	Varicose Veins (Varicose Vein) 11/2020 - 05/2002
2	Microsatellite Instability 10/2020 - 07/2020

Drug/Important Bio-Agent (IBA)

53	InterferonsIBA 12/2020 - 07/2006
36	Ribavirin (Virazole)FDA LinkGeneric 12/2020 - 01/2007
29	Antiviral Agents (Antivirals)IBA 02/2022 - 05/2012
18	daclatasvirIBA 01/2020 - 01/2014
17	lenvatinibIBA 04/2022 - 01/2019
16	Sorafenib (BAY 43-9006)FDA Link 01/2021 - 12/2014
16	asunaprevirIBA 01/2020 - 01/2015
13	Proteins (Proteins, Gene)FDA Link 10/2022 - 11/2006
11	RNA (Ribonucleic Acid)IBA 01/2020 - 06/2008
10	AntigensIBA 01/2021 - 02/2006
9	telaprevirIBA 06/2016 - 09/2011
8	Alanine Transaminase (SGPT)IBA 01/2021 - 08/2007
8	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 03/2005
8	SofosbuvirIBA 12/2020 - 04/2015
7	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2021 - 01/2017
6	Pharmaceutical PreparationsIBA 08/2019 - 11/2006
6	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2018 - 07/2010
6	Lamivudine (Epivir)FDA Link 08/2010 - 11/2005
5	Glucose (Dextrose)FDA LinkGeneric 03/2022 - 03/2014
5	NucleosidesIBA 01/2022 - 05/2007
5	EnzymesIBA 02/2021 - 05/2007
5	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021 - 07/2012
5	Immunoglobulins (Immunoglobulin)IBA 01/2021 - 08/2009
5	CytokinesIBA 01/2020 - 09/2010
4	Cisplatin (Platino)FDA LinkGeneric 06/2022 - 09/2002
4	Hemoglobins (Hemoglobin)IBA 03/2022 - 06/2011
4	regorafenibIBA 01/2021 - 09/2018
4	Protease Inhibitors (Protease Inhibitor)IBA 04/2020 - 07/2010
4	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2018
4	NucleotidesIBA 01/2019 - 10/2013
4	SimeprevirIBA 03/2017 - 06/2016
3	Bevacizumab (Avastin)FDA Link 04/2022 - 08/2021
3	atezolizumabIBA 04/2022 - 08/2021
3	glecaprevir and pibrentasvirIBA 01/2021 - 09/2019
3	Immunoglobulin G (IgG)IBA 01/2021 - 06/2008
3	Prothrombin (Factor II)IBA 01/2021 - 12/2014
3	Tyrosine Kinase InhibitorsIBA 01/2021 - 01/2020
3	velpatasvirIBA 12/2020 - 09/2019
3	Fetal Proteins (Fetoprotein)IBA 11/2020 - 07/2016
3	ChemokinesIBA 07/2019 - 01/2011
3	Tumor Biomarkers (Tumor Markers)IBA 01/2019 - 04/2015
3	entecavir FDA Link 12/2018 - 12/2007
3	ledipasvirIBA 12/2018 - 04/2017
3	Hepatitis B e AntigensIBA 01/2018 - 07/2006
3	Complementary DNA (cDNA)IBA 05/2017 - 01/2011
3	Interferon LambdaIBA 09/2015 - 02/2011
3	MicroRNAs (MicroRNA)IBA 03/2015 - 01/2012
3	Amino Acids FDA Link 09/2011 - 01/2005
3	Interferon-alpha (Interferon Alfa)IBA 10/2007 - 01/2007
2	Blood Glucose (Blood Sugar)IBA 03/2022 - 01/2018
2	Circulating Tumor DNAIBA 06/2021 - 09/2015
2	Immune Checkpoint InhibitorsIBA 02/2021 - 10/2020
2	Prednisolone (Predate)FDA LinkGeneric 02/2021 - 01/2014
2	Methylprednisolone FDA LinkGeneric 01/2021 - 01/2014
2	GlucocorticoidsIBA 01/2021 - 01/2014
2	HLA-DQB1 antigen (HLA DQB1)IBA 12/2020 - 01/2013
2	pembrolizumabIBA 10/2020 - 07/2020

Therapy/Procedure

93	Therapeutics 10/2022 - 07/2006
16	Drug Therapy (Chemotherapy) 06/2022 - 11/2011
16	Liver Transplantation 01/2021 - 08/2008
6	Radiotherapy 10/2021 - 11/2011
4	Hepatectomy 08/2019 - 12/2014
4	Surgical Portasystemic Shunt (Portosystemic Shunt) 08/2019 - 07/2013
2	Glycemic Control 03/2022 - 03/2014
2	Gastrectomy 07/2021 - 06/2011
2	Retreatment 12/2020 - 04/2018